Treatment of Right Bundle Branch Block
Isolated, asymptomatic right bundle branch block (RBBB) requires no treatment—permanent pacing is not indicated and has no proven mortality benefit. 1, 2
Clinical Approach Algorithm
1. Asymptomatic Isolated RBBB
- No intervention required (Class III recommendation) 1, 2
- The progression rate to complete AV block is only 1-2% per year 2
- Cardiac pacing has not been proven to reduce mortality in this population 2
- Simply observe with routine follow-up
2. RBBB with Syncope
This requires aggressive evaluation to determine if the syncope is cardiac in origin:
- Perform electrophysiological study (EPS) to assess conduction system
- If HV interval ≥70 ms OR infranodal block demonstrated: Permanent pacemaker is indicated (Class I) 1, 2
- If EPS is negative: Consider implantable loop recorder, as ~50% still develop documented AV block 2
- If syncope cause remains unexplained after workup: Pacing may be considered in selected elderly patients, especially if syncope was unpredictable, occurred supine, or during exertion (Class IIb) 2
Critical caveat: Less than half of patients with bundle branch block and syncope actually have cardiac syncope—vasodepressor mechanisms are common. Don't rush to implant a pacemaker without proper evaluation 2.
3. Alternating Bundle Branch Block
- Permanent pacemaker immediately indicated (Class I) 1, 2
- This pattern (RBBB alternating with LBBB on successive ECGs) indicates unstable disease in both bundles
- High risk of sudden complete heart block with inadequate escape rhythm
- Implant even without symptoms
4. RBBB in Bifascicular Block Context
When RBBB occurs with left anterior or posterior fascicular block:
- Asymptomatic: No pacing indicated 3, 4
- With syncope and positive EPS (HV ≥70 ms): Permanent pacing indicated (Class I) 2
- With documented intermittent 2nd or 3rd degree AV block: Permanent pacing indicated 3
5. RBBB with Specific Underlying Diseases
Neuromuscular diseases (Kearns-Sayre syndrome, myotonic dystrophy, Erb dystrophy):
- Permanent pacing reasonable even without symptoms due to unpredictable progression (Class IIa-I) 4, 1
- Consider defibrillator capability if meaningful survival >1 year expected 1
Anderson-Fabry disease with QRS >110 ms:
- Pacing may be considered (Class IIb) 1
6. RBBB in Acute Coronary Syndrome
- New-onset RBBB with chest pain should be treated as STEMI equivalent 5, 6
- Indicates proximal LAD occlusion affecting septal perforators
- Associated with larger infarcts, cardiogenic shock, and higher mortality 5, 6
- Requires urgent reperfusion therapy—this is a treatment emergency, not a pacing indication
7. RBBB with Heart Failure
- Traditional biventricular pacing less effective than in LBBB
- His bundle pacing shows promise: achieved QRS narrowing (158→127 ms) and LVEF improvement (31%→39%) in patients with RBBB and reduced ejection fraction 7
- Consider specialized centers for conduction system pacing if symptomatic heart failure with RBBB
Key Pitfalls to Avoid
Don't pace asymptomatic isolated RBBB—this is explicitly contraindicated and wastes resources 1, 2
Don't assume all syncope in RBBB patients is cardiac—vasovagal mechanisms are common. Perform carotid sinus massage and tilt table testing before committing to pacemaker 2
Don't miss alternating bundle branch block—review all available ECGs carefully, as this mandates immediate pacing 1
Don't overlook underlying neuromuscular disease—ask about progressive weakness, ophthalmoplegia, family history. These patients need pacing even if currently asymptomatic 4, 1
In acute settings, differentiate new RBBB (potential MI) from chronic RBBB—obtain old ECGs whenever possible 5, 6
Evidence Quality Note
The strongest recommendations come from the 2018 ACC/AHA/HRS guidelines 1 and 2013 ESC guidelines 2, which provide Class I evidence for pacing in alternating BBB and syncope with positive EPS, but Class III (harm) evidence against pacing asymptomatic isolated conduction disease. The progression rate of isolated RBBB to complete heart block is sufficiently low that prophylactic pacing provides no benefit and exposes patients to procedural risks and device complications.